via phys.org
An expert in environmental toxins at The University of Nottingham has developed a new antifungal technology which has the potential to play a major role in securing future food supplies.
Blocking fungal growth
Professor Simon Avery from the University’s Faculty of Medicine and Health Sciences has discovered that two agents, when combined, affect the process of protein synthesis, and have the potential to effectively block fungal growth in certain types of fungi which cause disease in crops or in humans.
Crop losses due to fungal spoilage each year are equivalent to the amount of food that could feed up to four billion people. In the developed world, millions of tonnes of crops are ruined each year by fungi and the problem is especially acute in developing countries where access to fungicides is more limited.
One of the problems with fungicides is that in many cases, the fungi adapt to the treatment, which means that most fungicides are only effective for a limited period. The solution developed by the University uses two agents which should make it more difficult for the fungi to acquire resistance to the fungicide.
Field trials
Explaining how the technology works, Professor Avery said: “Protein synthesis is essential to enable organisms to grow. When these two agents are applied it causes errors in the synthesis process that stop the fungus growing.”
After making the breakthrough discovery, which is patented by the University, Professor Avery and his team received initial development support through the University’s HERMES scheme. This enabled him to secure additional funding from the Biotechnology and Biological Science and Research Council (BBSRC) to further develop the technology. Field trials will take place this summer to study the impact of the fungicides on crops which are subjected to different environmental conditions.
Read more: Breakthrough dual fungicide technology could help prevent crop failures
The Latest on: Antifungal technology
via Google News
The Latest on: Antifungal technology
- FMI Highlights Accelerating Sales of Antibiotics in the Corneal Ulcer Treatment Marketspaceon February 25, 2021 at 10:17 pm
FMI Highlights Accelerating Sales of Antibiotics in the Corneal Ulcer Treatment Marketspace Corneal ulcer is among the main sources of blindness, especially in developing regions, with factors ...
- Natural Superfoods to Boost Immunity During Rough Timeson February 25, 2021 at 10:00 pm
A strong immune system can help you stay healthy, which is especially important during cold and flu season and the ongoing pandemic.
- APTtm Formulation Combats Multi-Drug Resistant Candida auris: An Emerging Global Healthcare Threaton February 25, 2021 at 11:05 am
Advanced Penetration Technology, LLC, (APT) a Texas- and Indiana-based company specializing in innovative healthcare solutions for physicians and patients utilizing our proprietary APTtm formulations, ...
- Antifungal Drugs Market Size to Hit USD 13.17...on February 25, 2021 at 3:36 am
Rising awareness about personal safety and care is a key factor driving the global antifungal drugs market, says Fortune ...
- Anti-microbial/Anti-fungal Tests Market Research Report 2021 Covers Updated Data Considering Impact of Covid 19 on Share Size and Future Demandon February 23, 2021 at 7:22 pm
The Anti-microbial/Anti fungal Tests Market is expected to exceed more than US$ 250 Million by 2024. The Anti-microbial/Anti-fungal Tests Market is segmented on the lines of its test types, type, ...
- Specific inactivation of an antifungal bacterial siderophore by a fungal plant pathogenon February 21, 2021 at 4:00 pm
Pyochelin is a siderophore produced by many Pseudomonas and Burkholderia species that induces systemic resistance in plants and has been identified as an antifungal agent.
- Awaiting FDA decision on ibrexafungerp, Scynexis deals greater China rights to Hansohon February 20, 2021 at 7:55 am
HONG KONG – Hansoh Pharmaceutical Group Co. Ltd. picked up the greater China rights to Scynexis Inc.’s lead candidate, ibrexafungerp. Under the terms, Hansoh will take charge of the development, ...
- SCYNEXIS and Hansoh Pharma Announce Licensing Agreement and Strategic Partnership for Ibrexafungerp in Greater Chinaon February 17, 2021 at 5:27 am
SCYNEXIS, Inc. (NASDAQ: SCYX ), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, and Hansoh Pharmaceutical Group ...
- Global Suspended Lamps Market Report 2021 to 2025 Market Analysis, Size, Share, Trends, Key Players, Drivers and Forecaston February 17, 2021 at 2:14 am
Eon Market Research has recently added a concise research on Suspended Lamps Market by Evolving Technology Industry Strategies Business Competitors Growth rate Key Companies and Forecast to 2025 ...
- Global Topical Antifungal Agents Market 2021: Comprehensive Study by Leading Key Players in Industryon February 17, 2021 at 2:13 am
Eon Market Research has recently added a concise research on Topical Antifungal Agents Market by Evolving Technology, Industry Strategies, Business Competitors, Growth rate, Key Companies and ...
via Bing News
